Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Igor Eduardo
Observed name:
Eduardo, Igor
Institution:
Eterna Massive Open Laboratory
Observed institution:
Eterna Massive Open Laboratory
ORCID:
0009-0005-6288-1135
Observed ORCID:
0009-0005-6288-1135
OpenAlex ID:
A5078589617
BM25 and Dense Retrieval Are Complementary for Portuguese Clinical Text: An Empirical Study of Hybrid RAG Across 500 Clinical Queries
2026
·
Igor Eduardo
·
Research Square
·
1
PDF
Brazilian-PHI: Benchmarking Checksum-Validated Recognizers for CPF, CRM, CNS, CNPJ, RG, CEP, and Phone in Portuguese Clinical Text
2026
·
Igor Eduardo
·
Research Square
·
1
PDF
Quiet prompt injections leak Brazilian patient identifiers from clinical LLM assistants: an evaluation in Inspect with mitigation baselines and LGPD analysis
2026
·
Eduardo, Igor
·
Zenodo (CERN European Organization for Nuclear Research)
Substance-Level Disproportionate Reporting of Impaired Gastric Emptying for Five Glucagon-Like Peptide-1 Receptor Agonists: A Reproducible Signal-Detection Analysis of the FDA Adverse Event Reporting System
2026
·
Igor Eduardo
·
Research Square
Class-Wide Disproportionate Reporting of Impaired Gastric Emptying Across Nine Glucagon-Like Peptide-1 Receptor Agonist Products: A Signal-Detection Analysis of the FDA Adverse Event Reporting System
2026
·
Igor Eduardo
·
Research Square
Record-breaking dengue epidemic in Brazil, 2024: nationwide analysis of 10.5 million cases and DENV-3 reemergence
2026
·
Igor Eduardo
·
Research Square
PDF
Hidden in plain sight: national benchmarks for sepsis mortality, dengue burden, and antimicrobial use from 35 million hospitalizations in Brazil's universal health system
2026
·
Igor Eduardo
·
Research Square
PDF
Comparative Post-Marketing Pharmacovigilance of Five GLP-1 Receptor Agonists: A Disproportionality Analysis of 412,643 FDA Adverse Event Reports (2004-2024)
2026
·
Igor Eduardo
·
Research Square
Class-Wide Impaired Gastric Emptying Signal Across Nine GLP-1 Receptor Agonist Agents: Indication-Stratified Pharmacovigilance Analysis of 6,868 Cases in FDA FAERS (2004-2024) with Cross-National Validation
2026
·
Igor Eduardo
·
Research Square
PDF
Hidden in plain sight: national benchmarks for sepsis mortality, dengue burden, and antimicrobial use from 35 million hospitalizations in Brazil's universal health system
2026
·
Eduardo, Igor
·
Zenodo (CERN European Organization for Nuclear Research)
Hidden in plain sight: national benchmarks for sepsis mortality, dengue burden, and antimicrobial use from 35 million hospitalizations in Brazil's universal health system
2026
·
Eduardo, Igor
·
Zenodo (CERN European Organization for Nuclear Research)
Hidden in plain sight: national benchmarks for sepsis mortality, dengue burden, and antimicrobial use from 35 million hospitalizations in Brazil's universal health system
2026
·
Eduardo, Igor
·
Zenodo (CERN European Organization for Nuclear Research)
Epidemiological Characterization of the 2024 Brazilian Dengue Epidemic: A Multi-Source Analysis Using SINAN, SIH, and InfoDengue
2026
·
Eduardo, Igor
·
Zenodo (CERN European Organization for Nuclear Research)
GLP-1 FAERS Pharmacovigilance Pre-registration 2024
2026
·
Eduardo, Igor
GLP-1 FAERS Pharmacovigilance Pre-registration 2024
2026
·
Eduardo, Igor
·
Open Science Framework
Show more works
View as search
Works count:
16
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type
